Molecular Basis for Immunological Diseases: Insights from the Latin-American Region
Location: Salons 5-6
Organized ByInstitut Pasteur de Montevideo, Latin American and Caribbean Association of Immunology, Mexican Translational Immunology Research Group, Millennium Institute on Immunology and Immunotherapy (MIII), FCE Centre of Translational Immunology (CTI), FCE Vaccines and ImmunoTherapies against Infections and Cancers (VITIC)
12:00 PM - 3:00 PM PST
Pathogenic B Cells in Autoimmunity: Genetic Drivers, Disease Endotypes and Therapeutic Targets
Location: Salons 10-11
Organized By
1:00 PM - 2:45 PM PST
In Vivo CAR T cell Generation: An Industry View Approach (Open to All Attendees)
Microbiota-immune Interactions in Neuroinflammation
Location: Salon 8
Speaker: Anne-Katrin Pröbstel, MD, PhD – University of Bonn, University Hospital Bon, Center for Neurology and Clinic for Neuroimmunology and for Neuromuscular Diseases
4:00 PM - 4:30 PM PST
Gut-associated Lymphoid Tissue: Protecting a Hostile Frontier
Lesional and Perilesional Tissue Comparisons Across Immune-Mediated Inflammatory Diseases Reveal Disease-Specific Immunoregulatory Mechanisms Mediated by Peripheral Helper and Regulatory T Cells
Translational Application of TEAD Inhibitors to Overcome Immunotherapy Resistance in Solid Tumors: Clinical and Preclinical Mechanistic Supportive Data
Location: Salon 8
Presenting Author: Meriem Taleb – Memorial Sloan Kettering Cancer Center
Immuno-oncology
5:30 PM - 5:45 PM PST
Engineering Stable and Lymphodepletion-resistant Regulatory T Cell Therapy for Inducing Immune Tolerance in Transplantation and Autoimmunity
AI-based Integration of Genetic and Environmental Information to Determine Risk for Multiple Sclerosis
Location: Salon 7
Speaker: Sergio E. Baranzini, PhD – Weill Institute for Neurology Heidrich Family and Friends, Institute for Human Genetics, Graduate Program in Bioinformatics
10:25 AM - 10:40 AM PST
A Multi-ethnic Reference Map of TCR Germline Diversity Reveals Evidence of Natural Selection on Variable and Joining Alpha Chain Genes
Engineering Immunosuppression-resistant Allogeneic CD19 CAR T cells to Treat B cell-driven Autoimmune Disorders Without the Need for Glucocorticoid Weaning
Location: Salons 3-6
Presenting Author: Viktor Glaser – Charité - Universitätsmedizin Berlin
Immuno-engineering and Cellular Therapies
11:20 AM - 11:45 AM PST
Fine-Tuning Dendritic Cell Function to Overcome Tumor Immune Escape
Increased Glutamine Dependence of CD8 T cells in Human Critical Illness Drives Dysregulated Effector and Exhausted-Like Programming and Associates With Poor Clinical Outcomes
Location: Salons 3-6
Presenting Author: Casey M. Nichols – Vanderbilt University Medical Center
A Treg Cell-targeted IL-2m Results in Superior Suppression of Th2 Responses Compared to CD25-biased IL-2m and anti-IL4R Blockade in a Mouse Model of Asthma
Defining the Immunological Features of CD19 CAR T cell Therapy in MRL/lpr Mice
Location: Salon 7
Presenting Author: Tatiana Lau – University of British Columbia
Autoimmune Diseases
4:45 PM - 5:00 PM PST
Collagen-disrupting TIL-cell Therapy for Sarcoma
Location: Salon 7
Presenting Author: Shulin Li, PhD – The University of Texas MD Anderson Cancer Center
Immuno-engineering and Cellular Therapies
5:00 PM - 5:15 PM PST
CNP-104, an Antigen-Specific Tolerogenic Nanoparticle Therapy, Stabilizes Prognostic Trajectory and Liver Stiffness with a Link to Reduction in Pathogenic T-Cells in Primary Biliary Cholangitis
Non-ICANS Neurotoxicity Following BCMA CAR T-cell Therapy: Distinguishing Movement and Neurocognitive Toxicity from Peripheral Nervous System Manifestations
Speaker: Samra Turajlić, MD, PhD – Cancer Research UK Manchester Institute, The Francis Crick Institute, The Christie NHS Foundation Trust
7:00 PM - 8:15 PM PST
Exhibit and Poster Reception (Authors Present)
7:00 PM - 8:15 PM PST
Exhibit and Poster Reception (Authors Present)
Location: Salon 9
Sponsored By
Friday, June 12, 2026
7:00 AM - 12:30 PM PST
Registration Open
7:00 AM - 12:30 PM PST
Registration Open
Location: Registration Desk
8:00 AM - 9:30 AM PST
New Approaches to Immune-mediated Disease
Chair: Ricardo Grieshaber-Bouyer, MD – Friedrich-Alexander-Universität Erlangen-Nürnberg and University Hospital Erlangen
Co-Chair: Ann-Kathrin Götz – Friedrich-Alexander-Universität Erlangen-Nürnberg and University Hospital Erlangen; Harvard Medical School and Brigham and Women's Hospital
8:00 AM - 9:30 AM PST
New Approaches to Immune-mediated Disease
Location: Salon 8
Chair: Ricardo Grieshaber-Bouyer, MD – Friedrich-Alexander-Universität Erlangen-Nürnberg and University Hospital Erlangen
Co-Chair: Ann-Kathrin Götz – Friedrich-Alexander-Universität Erlangen-Nürnberg and University Hospital Erlangen; Harvard Medical School and Brigham and Women's Hospital
Sponsored By
8:00 AM - 8:30 AM PST
Resetting the Immune System by Deep B cell Depletion
Location: Salon 8
Speaker: Georg Schett, MD – University Hospital Erlangen, Friedrich-Alexander University Erlangen–Nuremberg